Log in to save to my catalogue

TWi Pharmaceuticals Updates on Resignation of President CEO Tina Guilder

TWi Pharmaceuticals Updates on Resignation of President CEO Tina Guilder

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1709583431

TWi Pharmaceuticals Updates on Resignation of President CEO Tina Guilder

About this item

Full title

TWi Pharmaceuticals Updates on Resignation of President CEO Tina Guilder

Publisher

Jacksonville: Close-Up Media, Inc

Journal title

Manufacturing Close - Up, 2015

Language

English

Publication information

Publisher

Jacksonville: Close-Up Media, Inc

More information

Scope and Contents

Contents

TWi Pharmaceuticals is a specialty pharmaceutical company based in Taipei, Taiwan, focusing on the development of high-entry-barrier generic prescription products ranging from oral controlled release dosage form to novel drug delivery systems including the utilization of nanoparticles, transdermal, and oral delivery systems.

Alternative Titles

Full title

TWi Pharmaceuticals Updates on Resignation of President CEO Tina Guilder

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1709583431

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1709583431

How to access this item